News Story: Full Text
Sponsored By
Cleveland Clinic Brain Tumor and Neuro-Oncology Center
Please Click On The Above Banner For More Details
Braintumor Website

 

NEOPHARM ANNOUNCES CINTREDEKIN BESUDOTOX POSTER PRESENTATION AT 55TH ANNUAL MEETING OF THE CONGRESS OF NEUROLOGICAL SURGEONS


Posted on: 10/05/2005

***FOR IMMEDIATE RELEASE***
CONTACT:
Paul Arndt, Corporate Communications Manager
parndt@neophrm.com
847-295-8678 x 215

NEOPHARM ANNOUNCES CINTREDEKIN BESUDOTOX POSTER PRESENTATION AT 55TH ANNUAL MEETING OF THE CONGRESS OF NEUROLOGICAL SURGEONS

(CNS)
Who/What: NeoPharm, Inc. (Nasdaq/NM: NEOL) cintredekin besudotox (IL13-PE38QQR) poster presentation

Why: Preliminary safety and tolerability data for cintredekin besudotox in the treatment of newly-diagnosed malignant glioma

Where: Hynes Convention Center
Digital Poster Center, Exhibit Hall D, 2nd Floor
Boston, MA
When: Monday, October 10 9:00 a.m. – 4:30 p.m.
Tuesday, October 11 9:00 a.m. – 4:30 p.m.

Wednesday, October 12 9:00 a.m. – 4:00 p.m.
Electronic Poster Format

Posters can be searched by Author, Name, or Title

Title: Convection-Enhanced Delivery of Cintredekin Besudotox (IL13-PE38QQR) Followed by Radiation Therapy without and with Temozolomide: A Phase I Study in Newly-Diagnosed Malignant Glioma Patients

Authors: Michael A. Vogelbaum, MD, PhD, John H. Sampson, MD, PhD, Sandeep Kunwar MD, Susan Chang, MD, Fredrick F. Lang, MD, Mark E. Shaffrey, MD, Anthony L. Asher, MD, David Croteau, MD, Kristen Parker, BS, Jeanne L. Dul, PhD, Jeffrey W. Sherman, MD, FACP, Raj K. Puri, MD, PhD

About NeoPharm, Inc.

NeoPharm, Inc., based in Lake Forest, Illinois, is a publicly traded biopharmaceutical company dedicated to the research, development and commercialization of new and innovative cancer drugs for therapeutic applications. The Company has a portfolio of cancer compounds in various stages of development. Additional information can be obtained by visiting NeoPharm's Website at: www.neophrm.com.


Click HERE to return to brain tumor news headlines


Home | Brain Tumor Guide | FAQs | Find A Treatment
Noteworthy Treatments | News | Virtual Trial | Videos | Novocure Optune® | Newsletter
Donations | Brain Tumor Centers | Survivor Stories | Temodar®
Fundraising For Research | Unsubscribe | Contact Us

Copyright (c) 1993 - 2019 by:
The Musella Foundation For Brain Tumor Research & Information, Inc
1100 Peninsula Blvd
Hewlett, NY 11557
888-295-4740